HIMS
📉 HIMS stock has fallen significantly but is now testing a crucial long-term support level (40-week/200-day moving average), potentially offering an attractive entry point for investors monitoring technical levels.
💰 HIMS boasts impressive fundamentals, including strong revenue growth (77-95% recent quarterly growth), expected future profit increases (117% in 2025, 46% in 2026), and increasing institutional ownership, signaling underlying business strength.
🛡️ As a US-focused online pharmacy platform disrupting the sector, HIMS appears largely insulated from the direct impacts of the current tariff war, reducing a key market risk.
@VisionariosBolsa:
“The first value I want to talk about is HIMS, okay? Hims is a company you probably know, and precisely one of the companies that has fallen the most in recent weeks. But beware, because it’s also one of the companies that had risen the most in 2024, one of Wall Street’s most beloved stocks. You probably already know this company, but why do I think this stock is interesting now to keep under surveillance? Well, precisely because, notice how if we change the chart type here, HIMS is currently at a super key average, a 200-session average on the weekly chart, a 40-week average that has been, in all these recent months, in recent years, precisely the reference average for this uptrend. It’s one of Wall Street’s most beloved stocks; it’s one of the stocks with the best fundamentals in the market. Notice that it’s a 6 billion company, we could say it’s a mid-cap company, which means it has a lot of room for growth. But above all, its fundamentals are insane. Look how 2024 first quarter was profitable; 2025 is expected to generate 117% more profit than the previous year, and 2026 is already expected to generate 46% more profit than in 2025. How are funds positioning themselves? Quarter after quarter, non-stop. What are we seeing in those more basic fundamentals like quarterly sales, quarterly profit? Well, look how in recent quarters, always above 80%, 40%, 50%, and recent quarters already 77%, 95% quarterly growth in sales, truly insane. And the forecasts for upcoming quarters, look here, March ’25 estimates are already at 93%, 80% for the next one. What are we seeing in quarterly EPS? Well, look, triple digits every quarter, always growing above 100%. These numbers are truly insane. And precisely at this point where we are seeing that support of the 200-day average, we could be having super interesting support. Why, if it has such good numbers, is HIMS falling so much in recent weeks? Well, precisely because when the market falls, when there’s so much bearish pressure in the market like we’ve seen in recent weeks, it’s very possible that we see this type of movement. Now, is HIMS really a company that will suffer from tariffs? Well, if we look at the fundamentals and see the type of company HIMS is, which is nothing more than a mobile app that allows you to order pharmaceutical products online, well, hey, it’s really not a company exposed to this tariff war. In fact, it’s a company that only operates in the United States. What is this company doing? It’s changing a sector; it’s changing the pharmaceutical sector, making it so that if you need to buy any product, you don’t have to leave home. You have your Hims subscription, you can order your products. It’s also becoming very famous for its fat loss products, hair loss products, meaning it has a range of its own products that are also super powerful. And in fact, it’s one of the market leaders in its sector. Therefore, are we seeing in HIMS that these tariffs, this tariff war, blah blah blah, will end the company? Precisely not. We are seeing how there could be a good investment opportunity, okay? In fact, in this area above the 40-week average, it seems like a super interesting point. Beware, this doesn’t mean that if we touch that average, we will bounce back and go to highs. But in fact, it can be an interesting point to establish a first purchase. And if we see that we return to new lows, well, we could have a fairly simple stop. Why? Because remember that those averages, those support points, are always there until they fail. Well, when they fail, we know we can exit our position. But as long as we maintain that type of support in these areas, we could be facing an interesting long-term buying point in a company that, I repeat, may have a significantly higher risk level than the two companies I’m about to mention, but undoubtedly, I think it could be a stock that might be offering a good opportunity at these levels.”
Watch the exact part of the video where @VisionariosBolsa talks about Hims & Hers Health, Inc. here:
Watch the video on YouTube
Read more articles analyzing Hims & Hers Health, Inc. (HIMS) at the provided link. HIMS stock.
